| Metric | შპს ნეტ ფარმა საქართველო | შპს ჯორჯიან ფარმაცევტიკალსი | შპს ფორტრეს ფარმასიუტიკალ თრეიდინგ |
|---|---|---|---|
| Growth | |||
| Revenue | ₾8.7m₾6.0m | ₾6.6m₾7.0m | ₾19.5m₾15.6m |
| Revenue growth | 46.1% | -5.0% | 24.9% |
| Profitability | |||
| EBITDA | ₾2.9m₾2.0m | ₾1.9m₾1.7m | ₾790k₾3.5m |
| EBITDA margin | 33.4%34.0% | 29.4%24.4% | 4.1%22.6% |
| Net profit | ₾2.1m₾1.8m | ₾1.4m₾1.9m | |
| ₾790k₾3.5m |
| Net margin | 24.6%30.2% | 20.8%27.5% | 4.1%22.6% |
| Balance sheet | |||
| Total assets | ₾3.7m₾3.4m | ₾5.6m₾4.9m | ₾17.3m₾11.5m |
| Total equity | ₾1.9m₾2.0m | ₾5.1m₾4.0m | ₾3.8m₾3.6m |
| ROE | 114.1%92.1% | 27.0%48.0% | 21.1%97.0% |